Long -Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.  Maremmani I, Dematteis M, Gorzelanczyk EJ, Mugelli A, Walcher S, Torrens M.  J Clin Med. 2023 Aug 26;12(17):5575. doi: 10.3390/jcm12175575…

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl.  Chambers LC, Hallowell BD, Zullo AR, et al.  JAMA Netw Open. 2023;6(9):e2334540. doi:10.1001/jamanetworkopen.202…

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl.  Chambers LC, Hallowell BD, Zullo AR, et al.  JAMA Netw Open. 2023;6(9):e2334540. doi:10.1001/jamanetworkopen.202…

Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids.  Weimer, Melissa B. DO, MCR, DFASAM; Herring, Andrew A. MD; Kawasaki, Sarah S. MD, FASAM; Meyer, Marjorie MD; Kleykamp…

18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.  Rutrick D, Learned SM, Boyett B, Hassman D, Shinde S, Zhao Y.  J Subst Use Addict Treat…

Retrospective Comparison of the Effectiveness of Buprenorphine Versus Baclofen for Acute Opioid Withdrawal.  Hermenau M, Stamper B, Leung K, Pomm R, Guerrier C, Cammilleri J, Johnson B. A  HCA Healthc J Med. 2023 Apr 28;4(2):139-149. doi…